Adults 21 to 80, any sex, with Transfemoral Amputation or Artificial Limbs. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Time to Complete Sit-to-StandPrimary· Collection at baseline
The amount of time, measured in seconds, needed by the subject to complete the sit-to-stand transition. At least four trials of the sit-to-stand maneuver were collected for each participant using a motion analysis system. Average and standard deviation of the time to complete the sit-to-stand transition were calculated for each participant (each participant served as their own control in this pilot study). The start of the transition was determined by participant initiation; the end of the transition was determined by the participant reaching full knee extension.
Participant A
Group
Value
95% CI
Habitual Prosthesis
1.6
± 0.1
Participant B
Group
Value
95% CI
Habitual Prosthesis
2.2
± 0.2
Participant C
Group
Value
95% CI
Habitual Prosthesis
1.4
± 0.2
Time to Complete Sit-to-StandPrimary· After acclimation to Assist-Knee (Participants are given at least 10 minutes and no more than 60 minutes to acclimate to each Assist-Knee condition for safety. After acclimating, participants will complete the maneuver to measure this outcome.)
The amount of time, measured in seconds, needed by the subject to complete the sit-to-stand transition. At least four trials of the sit-to-stand maneuver were collected for each participant using a motion analysis system. Average and standard deviation of the time to complete the sit-to-stand transition were calculated for each participant (each participant served as their own control in this pilot study). The start of the transition was determined by participant initiation; the end of the transition was determined by the participant reaching full knee extension.
Participant A
Group
Value
95% CI
Assist-Knee (Settings 1)
3.4
± 0.6
Assist-Knee (Settings 2)
2.7
± 0.2
Participant B
Group
Value
95% CI
Assist-Knee (Settings 1)
6.4
± 1.3
Assist-Knee (Settings 2)
3.8
± 0.5
Participant C
Group
Value
95% CI
Assist-Knee (Settings 1)
2.4
± 0.5
Assist-Knee (Settings 2)
2.9
± 0.5
Timed Up and Go (TUG) TestSecondary· Collection at baseline
The Timed Up and Go (TUG) test is a validated timed functional test that involves standing up from a chair, walking forward for 3 meters, turning around, walking back to the chair for 3 meter, and sitting down. Each participant completed the TUG test for three trials. Time was measured using a stopwatch. Average and standard deviation of the time to complete the TUG test were calculated for each participant (each participant served as their own control in this pilot study).
Participant A
Group
Value
95% CI
Habitual Prosthesis
7.1
± 0.5
Participant B
Group
Value
95% CI
Habitual Prosthesis
13.7
± 1.0
Participant C
Group
Value
95% CI
Habitual Prosthesis
12.3
± 0.8
Timed Up and Go (TUG) TestSecondary· After acclimation to Assist-Knee (Participants are given at least 10 minutes and no more than 60 minutes to acclimate to each Assist-Knee condition for safety. After acclimating, participants will complete the maneuver to measure this outcome.)
The Timed Up and Go (TUG) test is a validated timed functional test that involves standing up from a chair, walking forward for 3 meters, turning around, walking back to the chair for 3 meter, and sitting down. Each participant completed the TUG test for three trials. Time was measured using a stopwatch. Average and standard deviation of the time to complete the TUG test were calculated for each participant (each participant served as their own control in this pilot study).
Participant A
Group
Value
95% CI
Assist-Knee (Settings 1)
12.3
± 1.1
Assist-Knee (Settings 2)
12.8
± 0.8
Participant B
Group
Value
95% CI
Assist-Knee (Settings 1)
25.0
± 3.0
Assist-Knee (Settings 2)
22.0
± 1.4
Participant C
Group
Value
95% CI
Assist-Knee (Settings 1)
20.8
± 3.5
Assist-Knee (Settings 2)
18.8
± 1.5
Time to Complete Stand-to-SitSecondary· Collection at baseline
The amount of time, measured in seconds, needed by the subject to complete the stand-to-sit transition. At least four trials of the stand-to-sit maneuver were collected for each participant using a motion analysis system. Average and standard deviation of the time to complete the stand-to-sit transition were calculated for each participant (each participant served as their own control in this pilot study). The start of the transition was determined by participant initiation; the end of the transition was determined by the participant being seated on a chair.
Participant A
Group
Value
95% CI
Habitual Prosthesis
2.7
± 0.1
Participant B
Group
Value
95% CI
Habitual Prosthesis
4.1
± 1.0
Participant C
Group
Value
95% CI
Habitual Prosthesis
1.6
± 0.2
Time to Complete Stand-to-SitSecondary· After acclimation to Assist-Knee (Participants are given at least 10 minutes and no more than 60 minutes to acclimate to each Assist-Knee condition for safety. After acclimating, participants will complete the maneuver to measure this outcome.)
The amount of time, measured in seconds, needed by the subject to complete the stand-to-sit transition. At least four trials of the stand-to-sit maneuver were collected for each participant using a motion analysis system. Average and standard deviation of the time to complete the stand-to-sit transition were calculated for each participant (each participant served as their own control in this pilot study). The start of the transition was determined by participant initiation; the end of the transition was determined by the participant being seated on a chair.
Participant A
Group
Value
95% CI
Assist-Knee (Settings 1)
4.4
± 0.4
Assist-Knee (Settings 2)
3.3
± 0.4
Participant B
Group
Value
95% CI
Assist-Knee (Settings 1)
4.9
± 1.7
Assist-Knee (Settings 2)
4.5
± 0.9
Participant C
Group
Value
95% CI
Assist-Knee (Settings 1)
2.5
± 0.1
Assist-Knee (Settings 2)
2.7
± 0.7
Percentage of Body Weight on Contralateral Limb at 65 Degrees Knee FlexionSecondary· Collection at baseline
The percentage of body weight on the contralateral limb was determined for both stand-to-sit and sit-to-stand transitions at 65 degrees knee flexion. A force plate under the contralateral limb recorded the amount of loading on the limb during the stand-to-sit and sit-to-stand transitions. The amount of contralateral limb loading at 65 degrees knee flexion was determined and divided by the participant's total loading due to overall body weight. This value was then converted to a percentage.
Participant A
Group
Value
95% CI
SIT With Habitual Prosthesis
79.2
± 2.8
STAND With Habitual Prosthesis
85.9
± 2.5
Participant B
Group
Value
95% CI
SIT With Habitual Prosthesis
61.8
± 11.4
STAND With Habitual Prosthesis
49.0
± 2.3
Participant C
Group
Value
95% CI
SIT With Habitual Prosthesis
87.0
± 3.6
STAND With Habitual Prosthesis
95.8
± 2.6
Percentage of Body Weight on Contralateral Limb at 65 Degrees Knee FlexionSecondary· After acclimation to Assist-Knee (Participants are given at least 10 minutes and no more than 60 minutes to acclimate to each Assist-Knee condition for safety. After acclimating, participants will complete the maneuver to measure this outcome.)
The percentage of body weight on the contralateral limb was determined for both stand-to-sit and sit-to-stand transitions at 65 degrees knee flexion. A force plate under the contralateral limb recorded the amount of loading on the limb during the stand-to-sit and sit-to-stand transitions. The amount of contralateral limb loading at 65 degrees knee flexion was determined and divided by the participant's total loading due to overall body weight. This value was then converted to a percentage.
Participant A
Group
Value
95% CI
SIT With Assist-Knee (Settings 1)
67.7
± 7.5
STAND With Assist-Knee (Settings 1)
82.0
± 1.9
SIT With Assist-Knee (Settings 2)
48.0
± 9.4
STAND With Assist-Knee (Settings 2)
83.5
± 1.2
Participant B
Group
Value
95% CI
SIT With Assist-Knee (Settings 1)
23.5
± 13.7
STAND With Assist-Knee (Settings 1)
27.0
± 6.9
SIT With Assist-Knee (Settings 2)
19.4
± 10.4
STAND With Assist-Knee (Settings 2)
31.3
± 2.3
Participant C
Group
Value
95% CI
SIT With Assist-Knee (Settings 1)
67.0
± 1.6
STAND With Assist-Knee (Settings 1)
78.6
± 4.5
SIT With Assist-Knee (Settings 2)
63.4
± 9.9
STAND With Assist-Knee (Settings 2)
76.4
± 3.2
Sponsor's own description
The purpose of this research is to validate the Assist-Knee design and function by collecting pilot data during the stand-to-sit-to-stand transition in transfemoral prosthesis users when using the Assist-Knee to harvest energy and return energy .
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT05729061 — Analysis of Human Movement With Assistive Devices
· NA
· recruiting
Other recruiting trials for Transfemoral Amputation
Currently open trials in the same condition.
NCT07204925 — Towards Efficient Personalization of Computerized Lower Limb Prostheses Via Reinforcement Learning in a Clinical Setup -
· Phase 1
· recruiting
NCT07204912 — Evaluation of a Neural-Controlled Powered Prosthesis Across Diverse Real-World Tasks
· NA
· recruiting
NCT06218238 — A Biomechanical Evaluation of the Ossur Power Knee in Persons With Transfemoral Amputation
· NA
· recruiting
NCT05695911 — Transfemoral Osseointegrated Prosthesis Limb-Load Symmetry Training
· NA
· active not recruiting
NCT05989243 — Improving Socket Fit in Female and Male Veterans With Transtibial and Transfemoral Amputation
· recruiting
Other Orthocare Innovations, LLC trials
Trials by the same sponsor.
NCT06023316 — mGain - sEMG-based Gamified Therapy for Improved Upper Limb Rehabilitation
· NA
· unknown
NCT05729061 — Analysis of Human Movement With Assistive Devices
· NA
· recruiting
NCT05619484 — Smart Ankle-Foot Orthosis to Improve Stroke Outcomes: Smart AFO
· Phase 2
· unknown
NCT05318690 — PlayGait: A Dynamic Exoskeleton
· NA
· terminated
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Orthocare Innovations, LLC
Last refreshed: 18 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04023045.